﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Hamadan University of Medical Sciences</PublisherName>
      <JournalTitle>Avicenna Journal of Clinical Microbiology and Infection</JournalTitle>
      <Issn>2383-0298</Issn>
      <Volume>13</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>09</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Anti-Inflammatory Effects of Ivermectin in Carrageenan-Induced Paw Edema in Rats</ArticleTitle>
    <FirstPage>159</FirstPage>
    <LastPage>166</LastPage>
    <ELocationID EIdType="doi">10.34172/ajcmi.3750</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farhang</FirstName>
        <LastName>Mehrnia</LastName>
      </Author>
      <Author>
        <FirstName>Erfan</FirstName>
        <LastName>Norouzifard</LastName>
      </Author>
      <Author>
        <FirstName>Hamid</FirstName>
        <LastName>Soraya</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0602-230X</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ajcmi.3750</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>07</Month>
        <Day>05</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Ivermectin has shown potential anti-inflammatory properties in some studies, although the results are conflicting. Therefore, this study investigated the anti-inflammatory effects of ivermectin in rats using the carrageenan-induced paw edema model. Methods: Thirty male Wistar rats were randomly assigned to carrageenan, dimethyl sulfoxide, and indomethacin groups and two ivermectin-treated (at 0.2 mg/kg and 10 mg/kg doses) groups (n=6 each). Paw edema was induced by the subcutaneous injection of carrageenan, and ivermectin was intraperitoneally injected at doses of 0.2 mg/kg and 10 mg/kg. Then, paw thickness was hourly measured for 5 hours. Finally, myeloperoxidase (MPO) activity, malondialdehyde (MDA) levels, and histopathological changes in paw tissues underwent assessment. Results: At the second hour post-carrageenan injection, ivermectin at 0.2 mg/kg (P&lt;0.01) reduced inflamed paw thickness. At the third hour, ivermectin at 0.2 mg/kg (P&lt;0.001) and 10 mg/kg (P&lt;0.01) also decreased inflamed paw thickness. Likewise, both doses of ivermectin (P&lt;0.01) contributed to a similar extent to diminishing inflammation at the fourth hour. Moreover, ivermectin at doses of 0.2 mg/kg and 10 mg/kg could reduce MPO activity (P&lt;0.01) and MDA levels (P&lt;0.01), respectively. Ultimately, histopathological evaluation revealed a dose-dependent decline in leukocyte infiltration and inflammation in ivermectin-treated rats. Conclusion: Ivermectin demonstrated anti-inflammatory activity by decreasing paw edema, oxidative stress, neutrophil activity, and leukocyte infiltration, suggesting its potential as an anti-inflammatory agent.  </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Inflammation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Carrageenan</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ivermectin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Edema</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oxidative stress</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>